blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4039814

EP4039814 - METHOD FOR PRODUCING HEPARIN-LIKE SUBSTANCE, RECOMBINANT CELLS AND METHOD FOR PRODUCING SAME [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  08.07.2022
Database last updated on 15.07.2024
FormerThe international publication has been made
Status updated on  10.04.2021
Most recent event   Tooltip03.05.2024New entry: Application deemed to be withdrawn: despatch of communication + time limit 
Applicant(s)For all designated states
Kyushu University, National University Corporation
744, Motooka
Nishi-ku
Fukuoka-shi
Fukuoka 819-0395 / JP
For all designated states
National University Corporation Chiba University
1-33, Yayoi-cho
Inage-ku
Chiba-shi, Chiba 263-8522 / JP
For all designated states
Kyowa Hakko Bio Co., Ltd.
1-6-1 Otemachi
Chiyoda-ku
Tokyo 100-8185 / JP
[2022/32]
Inventor(s)01 / KAMIHIRA Masamichi
c/o KYUSHU UNIVERSITY, NATIONAL UNIVERSITY
CORPORATION, 744, Motooka, Nishi-ku
Fukuoka-shi, Fukuoka 819-0395 / JP
02 / KAWABE Yoshinori
c/o KYUSHU UNIVERSITY, NATIONAL UNIVERSITY
CORPORATION, 744, Motooka, Nishi-ku
Fukuoka-shi, Fukuoka 819-0395 / JP
03 / SAGAWA Kosuke
c/o KYUSHU UNIVERSITY, NATIONAL UNIVERSITY
CORPORATION, 744, Motooka, Nishi-ku
Fukuoka-shi, Fukuoka 819-0395 / JP
04 / TOIDA Toshihiko
c/o Graduate School of Pharmaceutical Sciences,
NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY
1-8-1, Inohana, Chuo-ku
Chiba-shi, Chiba 260-8675 / JP
05 / KOIZUMI Satoshi
c/o KYOWA HAKKO BIO CO., LTD., 1-6-1, Otemachi,
Chiyoda-ku
Tokyo 100-8185 / JP
 [2022/32]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstraße 3
81675 München / DE
[2022/32]
Application number, filing date20872500.202.10.2020
[2022/32]
WO2020JP37626
Priority number, dateJP2019018246702.10.2019         Original published format: JP 2019182467
[2022/32]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021066167
Date:08.04.2021
Language:JA
[2021/14]
Type: A1 Application with search report 
No.:EP4039814
Date:10.08.2022
Language:EN
[2022/32]
Search report(s)International search report - published on:JP08.04.2021
(Supplementary) European search report - dispatched on:EP12.09.2023
ClassificationIPC:C12P19/26, C12P19/04, C12N5/10, C07K14/705, C12N15/85
[2023/41]
CPC:
C07K14/705 (EP); C12P19/26 (EP,CN); C08B37/0075 (EP,US);
C07K14/4725 (CN); C08L5/10 (EP); C12N15/63 (US);
C12N15/85 (EP,CN); C12N5/0682 (CN,US); C12N5/10 (US);
C12N9/13 (EP,CN); C12Y208/02008 (EP,CN); C12Y208/02023 (EP,CN);
C12N2510/02 (CN); C12N2800/107 (CN); C12N2800/90 (EP);
C12N2840/203 (EP) (-)
Former IPC [2022/32]C12P19/04, C12N5/10, C12N15/12, C12N15/54, C12N15/63
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/32]
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON HEPARINÄHNLICHEN SUBSTANZEN, REKOMBINANTE ZELLEN UND VERFAHREN ZU DEREN HERSTELLUNG[2022/32]
English:METHOD FOR PRODUCING HEPARIN-LIKE SUBSTANCE, RECOMBINANT CELLS AND METHOD FOR PRODUCING SAME[2022/32]
French:PROCÉDÉ DE PRODUCTION D'UNE SUBSTANCE DU TYPE HÉPARINE, CELLULES RECOMBINANTES ET LEUR PROCÉDÉ DE PRODUCTION[2022/32]
Entry into regional phase30.03.2022Translation filed 
30.03.2022National basic fee paid 
30.03.2022Search fee paid 
30.03.2022Designation fee(s) paid 
30.03.2022Examination fee paid 
Examination procedure30.03.2022Examination requested  [2022/32]
26.10.2022Amendment by applicant (claims and/or description)
02.05.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
Fees paidRenewal fee
24.10.2022Renewal fee patent year 03
23.10.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XA]US5486599  (SAUNDERS SCOTT [US], et al) [X] 11,13 * page 2, column 3, line 9 - line 24; examples 6, 9 * [A] 1,6,10,14;
 [A]WO2018112434  (TEGA THERAPEUTICS INC [US]) [A] 1,11,14* the whole document *;
 [A]US10385143  (WHITELOCK JOHN M [AU], et al) [A] 1,11,14 * the whole document *
International search[XA]WO0140267  (YEDA RES & DEV [IL], et al) [X] 11,13-14 * 13 31-13 3, 2 * [A] 1-10, 12;
 [A]US2004043447  (SARIBAS SAMI [US], et al) [A] 1-12 * [0006] - [0 00 7] *;
 [A]JP2008515417  [A] 1-12;
 [A]  - BAIK, J. Y. et al., "Metabolic engineering of Chinese hamster ovary cells: Towards a bioengineered heparin", Metabolic Engineering, (20120000), vol. 14, doi:10.1016/j.ymben.2012.01.008, ISSN 1096-7176, pages 81 - 90, XP028466088 [A] 1-12 * 8 1 8 3 2,2. 8 5 -8 6 3.2 . -3.3.,8 6 2 *

DOI:   http://dx.doi.org/10.1016/j.ymben.2012.01.008
 [A]  - JALKANEN, Markku, Elenius Klaus, Rapraeger Alan, "Syndecan: Regulator of cell morphology and growth factor action at the cell-matrix interface", Trends in Glycoscience and Glycotechnology, (19930000), vol. 5, no. 22, doi:10.4052/tigg.5.107, ISSN 0915-7352, pages 107 - 120, XP055811043 [A] 1-12 * 1 0 7 *

DOI:   http://dx.doi.org/10.4052/tigg.5.107
 [A]  - YANG, Yang, Yaccoby Shmuel, Liu Wei, Langford J. Kevin, Pumphrey Carla Y., Theus Allison, Epstein Joshua, Sanderson Ralph D., "Soluble syndecan-1 promotes growth of myeloma tumors in vivo", Blood, (20020000), vol. 100, no. 2, doi:10.1182/blood.V100.2.610, ISSN 0006-4971, pages 610 - 617, XP055811048 [A] 1-12 * 610, 611 3 *

DOI:   http://dx.doi.org/10.1182/blood.V100.2.610
by applicantJPS63299
 JPH02227075
 JPH0322979
 WO9710354
 US6001358
 WO2010143698
 JP2019182467
    - GUERRINI et al., Nat. Biotechnol., (20080000), vol. 26, pages 669 - 675
    - Trends in Glycoscience and Glycotechnology, (19930000), vol. 5, no. 22, pages 107 - 120
    - Journal of Experimental Medicine, (19580000), vol. 108, page 945
    - Proc. Natl. Acad. Sci. USA, (19680000), vol. 60, page 1275
    - Genetics, (19680000), vol. 55, page 513
    - Chromosoma, (19730000), vol. 41, page 129
    - Methods in Cell Science, (19960000), vol. 18, page 115
    - Radiation Research, (19970000), vol. 148, page 260
    - Proc. Natl. Acad. Sci. USA, (19800000), vol. 77, page 4216
    - Proc. Natl. Acad. Sci., (19680000), vol. 60, page 1275
    - Cell, (19750000), vol. 6, page 121
    - Molecular Cell Genetics, pages 883 - 900
    - BAIL JY et al., Metab Eng, (20120000), vol. 14, pages 81 - 90
    - "NCBI", Database accession no. NM _001006946.1
    - Nature, (19870000), vol. 329, page 840
    - Nucleic Acids Research, (19820000), vol. 10, page 6487
    - Proc. Natl. Acad. Sci. USA, (19820000), vol. 79, page 6409
    - Gene, (19850000), vol. 34, page 315
    - Nucleic Acids Research, (19850000), vol. 13, page 4431
    - Proc. Natl. Acad. Sci. USA, (19850000), vol. 82, page 488
    - J. Mol. Biol., (19900000), vol. 215, page 403
    - Nucleic Acids Res., (19970000), vol. 25, page 3389
    - Genome Res., vol. 7, (19970000), page 649, URL: https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch&BLAST_SPEC=blast2seq&LINK_LOC=align2seq
    - Cytotechnology, (19900000), vol. 3, page 133
    - J. Biochemistry, (19870000), vol. 101, page 1307
    - WIGLER et al., Cell, (19770000), vol. 11, page 223
    - Proc. Natl. Acad. Sci. USA, (19870000), vol. 84, page 7413
    - Cell Biology (Third Edition) A Laboratory Handbook, Elsevier Inc., (20060000), vol. 1
    - BAIL JY et al., Metab Engl, (20120000), vol. 4, pages 81 - 90
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.